Abstract
Europe Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth
Summary
GlobalData' s "Europe Coronary Stents Market: Revival of Drug Eluting Stents to
Drive Growth" report is an essential source of data and analysis on the Europe
coronary stents market with complete coverage by categories. The report
provides market landscape, competitive landscape and market trends information
on two market categories - bare metal stents and drug eluting stents. The
report identifies the key trends shaping and driving the dynamism in the
Europe coronary stents market. The report also provides insight on the
prevalent competitive landscape and on the emerging players which are expected
to bring significant shift in the market standing of the existing leaders. The
report also analyses the M&A landscape with special focus on the market
participants that have been the most M&A active. The report also provides
valuable insight on the pipeline products within the Europe coronary stents
market.
Scope
- The report provides market size data and information on two Europe coronary
stents market categories - bare metal stents and drug eluting stents.
-
Annualized market revenues data from 2001 to 2008, forecast forward for 7
years to 2015.
- Analysis and review of the key events and milestones that
will impact the future of the Europe coronary stents market. Each trend
independently researched to provide qualitative analysis of what the
implications on sectors are, and how are companies responding to these
trends.
- Insightful review of key industry drivers, restraints and
challenges which are likely to impact the Europe coronary stents market in the
long run.
- In-depth analysis of the M&A landscape with a strong emphasis
on the market players, likely to remain active in the near future.
- The
report also covers information on the leading market players, the competitive
landscape, and the leading pipeline products and technologies.
-
Comprehensive analysis of the most likely developments expected to bring a
shift to the market positions of the leading manufacturers.
- The report
is built using data and information sourced from proprietary databases,
primary and secondary research and in house analysis by GlobalData' s team of
industry experts.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving
the Europe coronary stents Market.
- Design and develop your product
development, marketing and sales strategies by identifying the market
categories poised for a strong growth.
- Exploit in-licensing and
out-licensing opportunities by identifying products that are most likely to
ensure a robust return.
- Identify key players best positioned to take
advantage of the emerging market opportunities by developing insight on the
prevalent and anticipated competitive landscape.
- Drive revenues by
understanding key trends, innovative products and technologies, market
segments and companies likely to impact the Europe coronary stents market in
future.
- Effectively plan your M&A and partnership strategies by
identifying companies with the most promising pipeline.
- Identify
emerging players with potentially strong product portfolio and create
effective counter-strategies to gain competitive advantage.
- What' s the
next being thing in the Europe coronary stents technology landscape? -
Identify, understand and capitalize.
Table of Contents
1 Table Of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2
Executive Summary 7
3 Coronary Stents Market Overview 8
3.1
Introduction and Definition 8
3.1.1 Coronary Stents 8
3.1.1.1 Bare
Metal Stents 8
3.1.1.2 Drug Eluting Coronary Stents 8
3.2 Market
Overview 9
3.2.1 Risk Factors for Coronary Disease 12
3.2.2 Conditions
Required for Stenting 12
3.3 Cross Category Analysis 13
3.3.1 Europe
Interventional Cardiology Market Cross Category Analysis (2001-2015) 13
3.4 Competitive Landscape 14
3.5 The Europe Coronary Stent Market: Trend
Analysis 16
3.5.1 Market Snapshot 16
3.5.2 Emergence of DES - Overview
16
3.5.2.1 Drug Eluting Stent (DES) Market: Drivers 17
3.5.2.2 Drug
Eluting Stent (DES) Market: Restraints 18
3.5.3 Stent Coatings 18
3.5.4 Stent Implantation Procedure - Overview 19
3.5.5 Key End Users
20
3.5.6 The Europe Coronary Stent Market: Key Challenges 20
3.5.7 The
Europe Coronary Stent Market: Drivers 20
3.5.7.1 Developments in Imaging:
Enhanced Accuracy of Implantation and Surgical Procedures 21
3.5.7.2
Increased obesity rates in some population groups enhances the demand for
Percutaneous Coronary Intervention (PCI) 21
3.5.7.3 Affordability of BMS
drives the growth for stenting procedures in Europe 21
3.5.7.4 Minimally
invasive surgery increasing demand for overall stenting procedures 21
3.5.7.5 The Next Generation of Hybrid Devices Could Increase Treatment Outcome
and Device Applicability 22
3.5.7.6 Growing patient awareness drives
uptake for overall stenting procedures 22
3.5.8 The Europe Coronary Stent
Market: Restraints 22
3.5.8.1 Alternative treatment options creating a
threat to the usage of coronary stents 22
3.5.8.2 Negative Publicity
Related To Stent Market Have Affected the Usage of DES 22
3.5.8.3
Consolidation of the Market Creates Barriers to Entry for Small Companies
Limiting Growth 23
3.5.9 Emerging Technologies in the Europe Coronary
Stent Market 24
3.5.9.1 Diamond like Carbon Coating (DLC) 24
3.5.9.2
Advanced Drug eluting coatings 24
3.5.9.3 Bioabsorbable Stents 24
3.5.9.4 Platinum Enriched Stainless Steel (PERSE) 26
3.5.9.5 Antibody
coated or gene therapy stents 26
3.6 Future Outlook and Implications:
Europe Coronary Stent Market 26
4 Mergers & Acquisitions 27
4.1
Mergers & Acquisitions in 2009 27
4.1.1 Boston Scientific Acquires Labcoat
27
4.2 Mergers & Acquisitions in 2007 27
4.2.1 Medtronic Acquires
Setagon 27
4.3 Mergers & Acquisitions in 2006 27
4.3.1 Abbott
Laboratories Acquires Vascular Business of Guidant From Boston Scientific
27
5 Coronary Stent Pipeline Products: Europe 28
5.1 Key Coronary
Stent pipeline products 28
6 Appendix 39
6.1 Research Methodology
39
6.2 Coverage 40
6.3 Secondary Research 41
6.4 Primary Research
41
6.5 Models 42
6.6 Forecasts 42
6.7 Expert Panels 42
6.8
GlobalData Consulting 43
6.9 Contact Us 43
6.10 Disclaimer 43
1.1 List of Tables
Table 1: Coronary Stent Market, Europe, Overall Revenue
($ mn), Historic, 2001 - 2008 11
Table 2: Coronary Stent Market, Europe,
Overall Revenue ($ mn), Forecast, 2008 - 2015 12
Table 3: Company Share in
the Europe Coronary Stent Market ($ mn) and (%), 2007 15
Table 4:
Drug-Eluting Stents Comparison 17
Table 5: Coatings on Drug Eluting Stents
19
Table 6: Key Companies with Bioabsorbable Stents in Pipeline 25
Table 7: Coronary Stent Pipeline Products By Equipment Type 28
Table 8:
Coronary Stent Pipeline Products By Development Stage 30
Table 9: Coronary
Stent Pipeline Products By Therapy Area 33
1.2 List of Figures
Figure 1: Coronary Stents Market Definition, Europe, 2008 8
Figure 2:
Segment Contribution By Type Of Coronary Stent (%), Europe, 2008 10
Figure
3: Coronary Stent Market, Europe, Overall Revenue ($ mn), 2001 - 2015 11
Figure 4: Europe Interventional Cardiology Market Cross Category Analysis
(2001-2015) 13
Figure 5: Company Share in the Europe Coronary Stent Market
(%), 2007 14
Figure 6: History of Coronary Artery Disease Prevention,
Europe, 2008 16
Figure 7: Diagrammatic Representation of Artery Before and
After Placing the Stent 20
Figure 8: Drivers and Restraints in the Europe
Coronary Stent Market 23
Figure 9: GlobalData Methodology 40
| 
